What is Acadia Pharmaceuticals's intangible purchases?

Acadia Pharmaceuticals (ACAD) reported intangible purchases of $0 in Q1 2026.

How has Acadia Pharmaceuticals's intangible purchases changed year-over-year?

Acadia Pharmaceuticals's intangible purchases decreased by 100.0% year-over-year, from $98.84M to $0.

What does intangible purchases mean?

Cash spent acquiring intangible assets such as patents, licenses, and other intellectual property.

Acadia Pharmaceuticals ACAD Intangible Purchases

Intangible Purchases at other companies

BiogenBIIB

$0-100%

Catalyst PharmaceuticalCPRX

$0—

PTC TherapeuticsPTCT

$156K-80.7%

BridgeBio PharmaBBIO

$0-100%

Amneal Pharmaceuticals, Inc.AMRX

$7.85M+86.9%

Jazz PharmaceuticalsJAZZ

$0-100%

Other financials

Income statement

See full

Revenue$268.1M+9.7%

Gross profit$243.3M+8.6%

Operating income-$4.6M-124%

Net income$3.6M-80.8%

EPS (diluted)$0.02-81.8%

Balance sheet

See full

Cash & equivalents$282.2M+29.6%

Total debt$50.8M-9.3%

Total equity$1.2B+63.1%

Total assets$1.6B+41.8%

Cash flow

See full

Operating cash flow$34.0M+67.2%

CapEx$5.2M—

Free cash flow$28.8M+41.6%

Valuation

See full

Market cap$3.87B+37.0%

Profitability

See full

Gross margin91.5%-0.6pp

Operating margin7.4%-16.2pp

Net margin34.3%+11.3pp

FCF margin18.9%—

Returns & leverage

See full

Return on equity37.3%+0.1pp

Debt / equity0×0.0×

Current ratio3.6×+0.7×

Where this comes from

Reported directly by Acadia Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireIntangibleAssets.

The official record: Acadia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Acadia Pharmaceuticals's intangible purchases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Acadia Pharmaceuticals's intangible purchases?: Acadia Pharmaceuticals (ACAD) reported intangible purchases of $0 in Q1 2026.
How has Acadia Pharmaceuticals's intangible purchases changed year-over-year?: Acadia Pharmaceuticals's intangible purchases decreased by 100.0% year-over-year, from $98.84M to $0.
What does intangible purchases mean?: Cash spent acquiring intangible assets such as patents, licenses, and other intellectual property.